Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR - Nasdaq - US83125X1037 - Common Stock - Currency: USD

8.97  +1.09 (+13.83%)

After market: 9.01 +0.04 (+0.45%)

Fundamental Rating

1

Taking everything into account, SNBR scores 1 out of 10 in our fundamental rating. SNBR was compared to 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of SNBR have multiple concerns. SNBR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SNBR has reported negative net income.
SNBR had a negative operating cash flow in the past year.
In multiple years SNBR reported negative net income over the last 5 years.
SNBR had a positive operating cash flow in 4 of the past 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

SNBR has a Return On Assets of -2.57%. This is in the lower half of the industry: SNBR underperforms 63.93% of its industry peers.
The Return On Invested Capital of SNBR (4.30%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SNBR is below the industry average of 12.03%.
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROIC 4.3%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin (1.66%) which is in line with its industry peers.
SNBR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 60.25%, SNBR belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 60.25%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SNBR is destroying value.
SNBR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNBR has less shares outstanding
The debt/assets ratio for SNBR is higher compared to a year ago.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of 0.24. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.24, SNBR is doing worse than 81.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACC0.47
WACC9.12%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.19, SNBR is doing worse than 97.54% of the companies in the same industry.
SNBR has a Quick Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.08, SNBR is doing worse than 97.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.08
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
Looking at the last year, SNBR shows a very negative growth in Revenue. The Revenue has decreased by -12.35% in the last year.
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%

3.2 Future

The Earnings Per Share is expected to grow by 36.29% on average over the next years. This is a very strong growth
Based on estimates for the next years, SNBR will show a decrease in Revenue. The Revenue will decrease by -0.23% on average per year.
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNBR. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 23.61, which indicates a rather expensive current valuation of SNBR.
The rest of the industry has a similar Price/Forward Earnings ratio as SNBR.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.36, SNBR is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 23.61
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNBR indicates a rather cheap valuation: SNBR is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.96
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

SNBR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SNBR's earnings are expected to grow with 42.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.63%
EPS Next 3Y42.99%

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SLEEP NUMBER CORP

NASDAQ:SNBR (7/23/2025, 8:00:02 PM)

After market: 9.01 +0.04 (+0.45%)

8.97

+1.09 (+13.83%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-16 2025-07-16/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners78.28%
Inst Owner Change-0.26%
Ins Owners7.03%
Ins Owner Change32.46%
Market Cap203.26M
Analysts48.89
Price Target6.63 (-26.09%)
Short Float %29.1%
Short Ratio9.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-721.69%
Min EPS beat(2)-1452.29%
Max EPS beat(2)8.9%
EPS beat(4)3
Avg EPS beat(4)-345.92%
Min EPS beat(4)-1452.29%
Max EPS beat(4)41.39%
EPS beat(8)4
Avg EPS beat(8)-162.76%
EPS beat(12)7
Avg EPS beat(12)-69.04%
EPS beat(16)8
Avg EPS beat(16)-59.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-6.21%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.35%
Revenue beat(12)3
Avg Revenue beat(12)-2.76%
Revenue beat(16)4
Avg Revenue beat(16)-3.27%
PT rev (1m)0%
PT rev (3m)-44.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.44%
EPS NY rev (1m)0%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.61
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.96
EPS(TTM)-0.95
EYN/A
EPS(NY)0.38
Fwd EY4.24%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS70.83
BVpS-20.16
TBVpS-23.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROCE -39.51%
ROIC 4.3%
ROICexc 4.32%
ROICexgc 5%
OM 1.66%
PM (TTM) N/A
GM 60.25%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexcg growth 3Y-45.92%
ROICexcg growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score5
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.17
Cap/Depr 29.51%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.08
Altman-Z 0.24
F-Score5
WACC9.12%
ROIC/WACC0.47
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%
EBIT growth 1Y-7.48%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year253.84%
EBIT Next 3Y61.41%
EBIT Next 5Y51.25%
FCF growth 1Y20.84%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-130.66%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%